COSM Financials 07/16/2014 12:58:57
Cosmos Holdings
COSM Financials 07/16/2014 12:58:57
Cosmos Holdings Inc.
Period Ending Dec 31, 2013 Jul 31, 2013 Dec 31, 2012 Jul 31, 2012
Total Revenue 902 - - -
Cost of Revenue 557 - - -
Gross Profit 345 - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 56 337 - 327
Non-Recurring Items - - - -
Other - - - -
Operating Income 289 (337) - (327)
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 289 (337) - (327)
Interest Expense 2 8 - 4
Earnings Before Tax 286 (345) - (331)
Income Tax 40 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 247 (345) - (331)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 247 (345) - (331)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 247 (345) - (331)
Cosmos Holdings Inc. (COSM) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Revolutionizing Cloud Mining with BCC Mining Cloud mining has witnessed significant advancements, particularly with the recent introduction of BCC Mining's mobile app. This development marks a new era for cryptocurrency enthusiasts, making it easier than ever to participate in mining activities. Users now have the flexibility to manage their mining operations from...
Continue Reading
CEFALY Introduces the Pregnancy Registry for Migraine Treatment Medical device company CEFALY Technology has recently announced the introduction of the CEFALY Pregnancy Registry, a research initiative aimed at assessing the safety of external trigeminal nerve stimulation (eTNS) for migraine treatment during pregnancy. The Challenge of Managing Migraines During Pregnancy...
Continue Reading
Velocity MSC Expands Offerings with Innovative 5G Communication Solution Velocity MSC, a trusted name in technological solutions, has announced an exciting addition to its service lineup. The company has incorporated DataRemote's advanced 90X1 5G Plain Old Telephone Service (POTS) replacement solution into its existing offerings. This innovative solution aligns with...
Continue Reading
Interleukin-23 Inhibitors Market Overview The interleukin-23 inhibitors market is currently experiencing significant growth, fueled by the escalating prevalence of autoimmune diseases such as psoriasis and inflammatory bowel disease. With innovations in biologics and increasing acceptance of targeted therapies, the demand for these treatments continues to surge....
Continue Reading
Hexagon Plans Spin-Off for Enhanced Focus and Growth Hexagon AB is embarking on an exciting journey towards the spin-off of its Asset Lifecycle Intelligence (ALI) division and associated businesses. This significant decision, made by the Board of Directors, aims to separate ALI into a new entity that will allow both Hexagon and the new organization, referred to as NewCo,...
Continue Reading